Skip to content

Braveheart Bio, Inc.

BRVE Nasdaq SEC CIK 2131524

Follow Braveheart Bio Weekly email: filings, results, news

News

9 stories filed under Braveheart Bio, grouped into ongoing threads

Initiates braveheart

Thread · 3 stories

Cantor Fitzgerald initiates Braveheart Bio stock with overweight rating

Markets 24 d ago

Jefferies initiates Braveheart Bio stock with buy on heart drug potential

Markets 24 d ago 2 sources

Goldman Sachs initiates Braveheart Bio stock coverage with buy rating

Markets 24 d ago 3 sources also on GS

IPO

Thread · 3 stories

Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors?

Deals 45 d ago

Braveheart Bio raises $439.9M in upsized Nasdaq IPO

Deals 48 d ago

Braveheart Bio prices $382.5M IPO at $18 per share

Deals 49 d ago 4 sources

More coverage

Insiders Are Betting Big on These 3 Healthcare Stocks

Markets 24 d ago

Braveheart Bio CEO Travis Murdoch Buys 83,333 Shares for $1.5 Million. Is This a Buy Signal for Investors?

Deals 45 d ago

Braveheart Bio shares surge 68% in New York trading debut

Markets 49 d ago

Profile

Headquarters: SAN FRANCISCO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 9 stories clustered from the RSS aggregator